Back to BAKER BROS. ADVISORS LP

ELVN
Showing 8 of 9 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in ENLIVEN THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 905,191 shares of ELVN (ENLIVEN THERAPEUTICS INC), worth $35.5M as of 2026-Q1. The position was increased (+233.5% shares). ELVN represents 0.2% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$35.5M

Current Shares

905,191

Total Value Change

+$32.8M

Total Shares Change

+790,358

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
905,191
+233.5%
$35.5M0.2%$28.75
56
2025-Q4
Increased
271,406
+136.3%
$4.2M0.0%$15.55
43
2025-Q3
Unchanged
114,833
0.0%
$2.4M0.0%$20.30
0
2025-Q2
Unchanged
114,833
0.0%
$2.3M0.0%$20.68
0
2025-Q1
Unchanged
114,833
0.0%
$2.3M0.0%$21.07
0
2024-Q4
Unchanged
114,833
0.0%
$2.6M0.0%$22.39
0
2024-Q3
Unchanged
114,833
0.0%
$2.9M0.0%$24.13
0
2024-Q2
Unchanged
114,833
0.0%
$2.7M0.0%$23.37
0

Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used